Breaking News, Financial News

Financial Report: Akorn 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Akorn Inc. Third Quarter Report 3Q Revenues: $14.5 million (+32%) 3Q Loss: $1.2 million (loss of $3.6 million in 3Q2005) YTD Revenues: $56.7 million (+68%) YTD Loss: $0.6 million (loss of $8.0 million in YTD2005) Comments: Two new contract manufacturing supply agreements were signed, one with GeneraMedix and one with Advanced Vision Research.The two agreements are projected to increase Contract Manufacturing sales by approximately 50% on an annual...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters